Table 1.
A † | B ‡ | hTII $ |
---|---|---|
A11–12 | Angiopoietin-2 | − |
A15–16 | BDNF | − |
C9–10 | FGF basic | − |
C13–14 | FGF-19 | − |
D7–8 | IFN-y | + |
D15–16 | IL-1α | − |
E3–4 | IL-5 | − |
E7–8 | IL-8 | + |
F13–14 | IL-32α/β/γ | + |
F19–20 | IP-10 | + |
F23–24 | Kallikrein 3 | − |
G5–6 | Lipocalin-2 | + |
G13–14 | MIF | − |
G23–24 | MMP-9 | − |
I7–8 | TARC/CCL17 | − |
I11–12 | TfR/CD71 | − |
J11–12 | VCAM-1 | + |
†, indicates the position on membrane of Figure 7; ‡, indicates the name of modified factors; $, indicates the results under IL4 stimulation: “−“ indicates that the factor is down-regulated.